Delivery Order SPE2DB20D1110-SPE2DB25FK39R
- Not listed
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,882.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Januvia 50 mg tablets (90-count packages). The contract, with an ultimate completion date of July 23, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. This...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units). The contract, which is not set-aside and was competitively awarded, calls for performance completion by August 18, 2025, with fulfillment at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,187.36 delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor agreement serves as a...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,819.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Januvia 100 mg tablets (90-count units). This non-set-aside contract, with an ultimate completion date of August 14, 2025, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $10,936.33. This non-set-aside award is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $9,111.37. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Januvia 50 mg tablets (90-count units). The contract, which represents a non-set-aside competitive award, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK39RDelivery Order
The Defense Logistics Agency awarded a $4,178.82 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for the Defense Logistics Agency's medical supply chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This delivery order for Januvia, an oral diabetes medication, exemplifies the routine pharmaceutical procurement activity conducted through the company's prime vendor agreement with DLA, which supports Defense Health Agency medical operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/9/25 |